Journal article
Stimulation of mTOR-independent autophagy and mitophagy by rilmenidine exacerbates the phenotype of transgenic TDP-43 mice
ND Perera, D Tomas, N Wanniarachchillage, B Cuic, SJ Luikinga, V Rytova, BJ Turner
Neurobiology of Disease | Published : 2021
Abstract
Autophagy, which mediates the delivery of cytoplasmic substrates to the lysosome for degradation, is essential for maintaining proper cell homeostasis in physiology, ageing, and disease. There is increasing evidence that autophagy is defective in neurodegenerative disorders, including motor neurons affected in amyotrophic lateral sclerosis (ALS). Restoring impaired autophagy in motor neurons may therefore represent a rational approach for ALS. Here, we demonstrate autophagy impairment in spinal cords of mice expressing mutant TDP-43Q331K or co-expressing TDP-43WTxQ331K transgenes. The clinically approved anti-hypertensive drug rilmenidine was used to stimulate mTOR-independent autophagy in d..
View full abstractGrants
Awarded by Motor Neurone Disease Research Institute of Australia
Funding Acknowledgements
We thank Servier (Paris) for generously providing rilmenidine. N.D. P. is supported by a Bill Gole Fellowship (1810) from the Motor Neurone Disease Research Institute of Australia. B.J.T. is a recipient of an Australian NHMRC-ARC Dementia Research Leadership Fellowship (1137024). This work was supported by grants from the Australian NHMRC (1104295) and Stafford Fox Medical Research Foundation.